Renalytix plc - RNLXY

Sector: Healthcare · Industry: Services-Medical Laboratories
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2024 · Q2 2024
Value (USD)
Total reported value ($000)
$595K
QoQ value delta ($000)
+$149K (+33.41%)
Implied price effect (QoQ)
+22.06%
Shares
Total shares
2,137,004
QoQ shares delta
+181,788 (+9.3%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (RNLXY)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2024)

Top 25 only Full list
Early Q3 2025 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
PINNACLE ASSOCIATES LTD 330 846,534 0.01%
STIFEL FINANCIAL CORP 102 489,431 0.0%
Corient Private Wealth LLC 70 335,514 0.0%
UBS Group AG 58 279,743 0.0%
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 13 63,739 0.0%
GEODE CAPITAL MANAGEMENT, LLC 11 53,311 0.0%
XTX Topco Ltd 4 20,197 0.0%
LPL Financial LLC 3 18,375 0.0%
CITADEL ADVISORS LLC 2 13,700 0.0%
OSAIC HOLDINGS, INC. 2 10,685 0.0%
JPMORGAN CHASE & CO 0 1 0.0%
WELLS FARGO & COMPANY/MN 0 3,400 0.0%
MORGAN STANLEY 0 2,200 0.0%
GROUP ONE TRADING LLC 0 174 0.0%